http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100618619-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28 |
| filingDate | 2004-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100618619-B1 |
| titleOfInvention | A composition for treating autoimmune diseases containing a carbon monoxide supply generated by hemeoxygenase-1 inducer or hemeoxygenase |
| abstract | The present invention relates to a composition for treating and preventing autoimmune diseases, which are T-cell related diseases, which contain hemeoxygenase-1 inducer or carbon monoxide supply as an active ingredient. The present invention also relates to an anti-inflammatory and anticancer composition comprising a hemeoxygenase-1 inducer or a carbon monoxide supply as an active ingredient. The composition according to the present invention can treat and prevent various diseases related to T-cells by inhibiting the proliferation of T-cells by inhibiting the production of IL-2 by carbon monoxide generated by hemeoxygenase-1.n n n n Hemeoxygenase-1, carbon monoxide, IL-2, T-cells, autoimmune diseases, rheumatoid arthritis, anti-inflammatory composition, anticancer composition |
| priorityDate | 2004-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 166.